Adenocarcinoma of Colon Completed Phase 1 / 2 Trials for Irinotecan (DB00762)

Back to Adenocarcinoma of Colon

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

IndicationStatusPhase
DBCOND0060083 (Adenocarcinoma of Colon)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551421
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerTreatment
NCT00005818
SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerTreatment